PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.40%
Revenue growth at 50-75% of 3088.T's 3.30%. Martin Whitman would worry about competitiveness or product relevance.
3.40%
Gross profit growth above 1.5x 3088.T's 2.23%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-2.91%
Negative EBIT growth while 3088.T is at 6.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
4.04%
Operating income growth at 75-90% of 3088.T's 4.50%. Bill Ackman would demand a plan to enhance operating leverage.
-15.54%
Negative net income growth while 3088.T stands at 6.03%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.54%
Negative EPS growth while 3088.T is at 6.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.54%
Negative diluted EPS growth while 3088.T is at 5.99%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 3088.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.00%
Diluted share change of 0.00% while 3088.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.57%
10Y revenue/share CAGR 1.25-1.5x 3088.T's 50.63%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
57.04%
5Y revenue/share CAGR above 1.5x 3088.T's 30.48%. David Dodd would look for consistent product or market expansions fueling outperformance.
29.96%
3Y revenue/share CAGR above 1.5x 3088.T's 8.78%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.45%
Below 50% of 3088.T's 193.52%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
86.04%
Below 50% of 3088.T's 311.03%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
9.43%
Below 50% of 3088.T's 24.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
130.07%
5Y equity/share CAGR above 1.5x 3088.T's 43.18%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
62.57%
3Y equity/share CAGR above 1.5x 3088.T's 21.69%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.20%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.35%
Inventory is declining while 3088.T stands at 2.89%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.06%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.14%
BV/share growth above 1.5x 3088.T's 1.23%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-41.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
96.39%
SG&A growth well above 3088.T's 25.30%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.